BIO-UV GROUP SAS (ALTUV.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALTUV - FR0013345493 - Common Stock
1.462 EUR
-0.03 (-2.01%)
ALTUV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 110 industry peers in the Machinery industry. ALTUV has only an average score on both its financial health and profitability. ALTUV is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ALTUV was profitable.
In the past year ALTUV had a positive cash flow from operations.
Each year in the past 5 years ALTUV has been profitable.
Of the past 5 years ALTUV 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.37%, ALTUV is doing worse than 65.45% of the companies in the same industry.
ALTUV has a worse Return On Equity (2.44%) than 68.18% of its industry peers.
The Return On Invested Capital of ALTUV (2.84%) is worse than 71.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 2.44% | ||
| ROIC | 2.84% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
1.3 Margins
ALTUV has a Profit Margin (2.64%) which is in line with its industry peers.
ALTUV's Profit Margin has declined in the last couple of years.
ALTUV has a Operating Margin (5.92%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ALTUV has grown nicely.
With a Gross Margin value of 38.14%, ALTUV perfoms like the industry average, outperforming 46.36% of the companies in the same industry.
ALTUV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.92% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% |
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALTUV is destroying value.
Compared to 1 year ago, ALTUV has about the same amount of shares outstanding.
The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
The debt/assets ratio for ALTUV has been reduced compared to a year ago.
2.2 Solvency
ALTUV has an Altman-Z score of 1.42. This is a bad value and indicates that ALTUV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALTUV (1.42) is worse than 68.18% of its industry peers.
The Debt to FCF ratio of ALTUV is 7.66, which is on the high side as it means it would take ALTUV, 7.66 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.66, ALTUV is in line with its industry, outperforming 42.73% of the companies in the same industry.
ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALTUV (0.39) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.66 | ||
| Altman-Z | 1.42 |
ROIC/WACC0.4
WACC7.16%
2.3 Liquidity
A Current Ratio of 2.07 indicates that ALTUV has no problem at all paying its short term obligations.
ALTUV's Current ratio of 2.07 is fine compared to the rest of the industry. ALTUV outperforms 79.09% of its industry peers.
A Quick Ratio of 1.33 indicates that ALTUV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, ALTUV is in the better half of the industry, outperforming 75.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.33 |
3. Growth
3.1 Past
ALTUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.00%, which is quite impressive.
ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -7.99%.
The Revenue has been growing by 14.65% on average over the past years. This is quite good.
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
3.2 Future
The Earnings Per Share is expected to grow by 14.51% on average over the next years. This is quite good.
ALTUV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.57% yearly.
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 20.89 indicates a rather expensive valuation of ALTUV.
Based on the Price/Earnings ratio, ALTUV is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
ALTUV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
ALTUV is valuated correctly with a Price/Forward Earnings ratio of 14.19.
ALTUV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 61.82% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.03. ALTUV is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 14.19 |
4.2 Price Multiples
ALTUV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 63.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALTUV indicates a rather cheap valuation: ALTUV is cheaper than 81.82% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.55 | ||
| EV/EBITDA | 8.71 |
4.3 Compensation for Growth
A more expensive valuation may be justified as ALTUV's earnings are expected to grow with 14.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3Y14.51%
5. Dividend
5.1 Amount
ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
ALTUV's Dividend Yield is a higher than the industry average which is at 1.55.
ALTUV's Dividend Yield is a higher than the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPA:ALTUV (12/24/2025, 7:00:00 PM)
1.462
-0.03 (-2.01%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.69M
Revenue(TTM)37.81M
Net Income(TTM)1.00M
Analysts86.67
Price Target3.06 (109.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)40%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.89 | ||
| Fwd PE | 14.19 | ||
| P/S | 0.55 | ||
| P/FCF | 7.55 | ||
| P/OCF | 4.34 | ||
| P/B | 0.5 | ||
| P/tB | 4.21 | ||
| EV/EBITDA | 8.71 |
EPS(TTM)0.07
EY4.79%
EPS(NY)0.1
Fwd EY7.05%
FCF(TTM)0.19
FCFY13.24%
OCF(TTM)0.34
OCFY23.06%
SpS2.67
BVpS2.9
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 2.44% | ||
| ROCE | 3.86% | ||
| ROIC | 2.84% | ||
| ROICexc | 2.84% | ||
| ROICexgc | 7.49% | ||
| OM | 5.92% | ||
| PM (TTM) | 2.64% | ||
| GM | 38.14% | ||
| FCFM | 7.25% |
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.42%
ROIC(3y)3.9%
ROIC(5y)3.05%
ROICexc(3y)4.1%
ROICexc(5y)3.43%
ROICexgc(3y)16.63%
ROICexgc(5y)12.76%
ROCE(3y)5.32%
ROCE(5y)4.17%
ROICexgc growth 3Y36.15%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.71%
ROICexc growth 5YN/A
OM growth 3Y21.76%
OM growth 5YN/A
PM growth 3Y-66.74%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | 7.66 | ||
| Debt/EBITDA | 3.36 | ||
| Cap/Depr | 79.92% | ||
| Cap/Sales | 5.37% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 99.79% | ||
| Profit Quality | 274% | ||
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.33 | ||
| Altman-Z | 1.42 |
F-Score7
WACC7.16%
ROIC/WACC0.4
Cap/Depr(3y)64.39%
Cap/Depr(5y)89.92%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6706.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%150%
EPS Next Y-29.92%
EPS Next 2Y0.06%
EPS Next 3Y14.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y2.74%
Revenue Next 3Y3.57%
Revenue Next 5YN/A
EBIT growth 1Y9.27%
EBIT growth 3Y28.77%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.4%
FCF growth 3Y105.48%
FCF growth 5YN/A
OCF growth 1Y18.95%
OCF growth 3Y27.9%
OCF growth 5YN/A
BIO-UV GROUP SAS / ALTUV.PA FAQ
Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?
ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.
What is the valuation status for ALTUV stock?
ChartMill assigns a valuation rating of 5 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.
What is the profitability of ALTUV stock?
BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.
How financially healthy is BIO-UV GROUP SAS?
The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.
What is the earnings growth outlook for BIO-UV GROUP SAS?
The Earnings per Share (EPS) of BIO-UV GROUP SAS (ALTUV.PA) is expected to decline by -29.92% in the next year.